MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Treatment"

  • 2022 International Congress

    Clinical and device-based predictors of improvement in motor experiences of daily living after a short-term multidisciplinary inpatient treatment: a cohort study

    R. Scherbaum, J. Oppermann, A. Moewius, V. Tschentscher, J. Geritz, J. Welzel, C. Hansen, R. Gold, W. Maetzler, L. Tönges (Bochum, Germany)

    Objective: To determine predictors of improvement in motor experiences of daily living (m-EDL) after a multidisciplinary inpatient ‘PD multimodal complex treatment’ (PD-MCT) and clarify the…
  • 2022 International Congress

    Feasibility of Sensor-Based Music Feedback In Patients With PD

    S. Mainka, G. Ebersbach (Beelitz-Heilstaetten, Germany)

    Objective: To assess the feasibility of sensor-based music feedback (SBMF) to improve arm swing (AS) and other gait parameters in patients with PD. Background: Reduction…
  • 2022 International Congress

    Transcutaneous auricular vagal nerve stimulation has frequency depended propensity to improve gait in Parkinson’s disease – a pilot study

    V. van Midden, Z. Pirtošek, G. Brecl Jakob, M. Kojović (Ljubljana, Slovenia)

    Objective: We used wearable inertion motion sensors (WMS) to compare the acute effects of transcutaneous auricular vagal stimulation (taVNS) at 100Hz (taVNS100), 25Hz (taVNS25), and…
  • 2022 International Congress

    Attending to Compensatory Strategies during Prolonged Walking in Parkinson Disease: A Pilot Study

    G. Yogev-Seligmann, M. Kafri (Haifa, Israel)

    Objective: 1. to compare the effects of compensatory strategies on the duration of attentive engagement during 10 min. walking, 2. to test associations between person's…
  • 2022 International Congress

    Progress of the UK Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial

    A. Bamford, S. Neumann, J. Taylor, G. Young, S. Emmett, W. Hollingworth, A. Whone, D. Steeds, C. Metcalfe, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: This abstract provides an overview of the progress of the CHIEF-PD trial. Background: Falls are a common and debilitating consequence of Parkinson’s disease (PD).…
  • MDS Virtual Congress 2021

    Compensation strategies for gait impairment in Parkinson’s disease: a survey among 4,324 patients

    A. Tosserams, L. Wit, I. Sturkenboom, M. Nijkrake, B. Bloem, J. Nonnekes (Nijmegen, Netherlands)

    Objective: The aim of this study was threefold: (1) to evaluate patients’ awareness and use of various compensation categories for gait impairments in PD; (2)…
  • MDS Virtual Congress 2021

    Validity and Reliability of Timed Get-Up and Go Test and Unified Parkinson’s disease Rating Scales on Parkinson ’s disease

    T. T (Bangalore, India)

    Objective: This study is an attempt to find the inter-rater and intra-rater reliability of both timed up and go test and unified Parkinson’s rating scale.…
  • MDS Virtual Congress 2021

    Levodopa responsive gait dynamics in ON- and OFF-state freezing of gait in Parkinson’s disease

    T. Virmani, L. Pillai, A. Glover, R. Landes (Little Rock, USA)

    Objective: To determine which spatiotemporal gait parameters respond to levodopa in Parkinson’s patients with levodopa ON- and OFF-state gait freezing. Background: Levodopa-ON-state gait freezing is…
  • MDS Virtual Congress 2021

    Gait Improvement in Pegzilarginase-treated Patients With Arginase 1 Deficiency: A Blinded Kinematic Analysis

    N. Foreman, G. Bubb, E. Bradford (Colleyville, USA)

    Objective: To assess the impact of pegzilarginase therapy on gait kinematics in Arginase 1 Deficiency (ARG1-D) patients. Background: High arginine levels in patients with ARG1-D…
  • MDS Virtual Congress 2021

    Associations between Baseline Cognitive Function and Gait Outcomes after Treadmill Training in Parkinson’s disease

    R. Amin, J. Phillips, A. Humbert, B. Cholerton, C. Zabetian, I. Mata, V. Kelly (Seattle, USA)

    Objective: To determine the effect of baseline cognition on gait outcomes after a gait training and aerobic exercise program in people with Parkinson's disease (PD).…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 30
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley